Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regulatable acetylcholine-producing fibroblasts enhance cognitive performance.

Donald P Pizzo1, Nicole G Coufal, Mark J Lortie

  • 1Department of Neurosciences, University of California at San Diego, VA Medical Center MC 9151, La Jolla, CA 92093-9157, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|September 28, 2005
PubMed
Summary

Regulatable gene therapy using choline acetyltransferase (ChAT) improved spatial cognition in rats after brain lesions. Doxycycline (DOX) silencing of ChAT expression abolished these cognitive benefits, demonstrating therapeutic potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurofibrillary tangle distribution in posterior cortical atrophy and typical early-onset Alzheimer's Disease.

Free neuropathology·2026
Same author

ESCRT-0 regulates AMPA receptor currents and Ca<sup>2+</sup>- dependent signaling.

bioRxiv : the preprint server for biology·2026
Same author

Milk as a Transmission Vehicle for Highly Pathogenic Avian Influenza A (H5N1).

Pediatrics·2026
Same author

BRD2 bromodomain-mediated regulation of cell state plasticity modulates therapy response in glioblastoma.

Neuro-oncology·2025
Same author

The cryo-EM-delineated mechanism underlying mimicry of CXCR4 agonism enables widespread stem cell neuroprotection in a mouse model of ALS.

bioRxiv : the preprint server for biology·2025
Same author

Intraventricular mass in a 49-year-old male.

Brain pathology (Zurich, Switzerland)·2025

Area of Science:

  • Neuroscience
  • Gene Therapy
  • Molecular Biology

Background:

  • Neurotransmitter imbalances, particularly acetylcholine, are implicated in cognitive decline.
  • Regulatable gene therapy offers precise control over neurotransmitter levels in vivo.
  • Developing effective strategies for treating single-gene disorders and understanding complex behaviors is crucial.

Purpose of the Study:

  • To investigate the therapeutic potential of a doxycycline-regulated choline acetyltransferase (ChAT) gene therapy system.
  • To assess the impact of ChAT gene therapy on cognitive function following cholinergic lesions in a rodent model.
  • To establish a method for spatiotemporal delivery of therapeutic compounds to study their behavioral effects.

Main Methods:

  • Development of a rodent fibroblast cell line engineered to express choline acetyltransferase (ChAT) cDNA, silenced by doxycycline (DOX).

Related Experiment Videos

  • Induction of cholinergic lesions using ibotenic acid in the nucleus basalis of rats.
  • Grafting of ChAT-expressing cells into lesioned rats, with one group receiving DOX to inhibit ChAT expression.
  • Behavioral testing using the water maze for spatial learning and memory, and open-field activity and inhibitory avoidance for other cognitive functions.
  • Molecular and biochemical analyses to confirm DOX-mediated regulation of transgene transcription and acetylcholine levels.

    • Main Results:

    • Rats receiving ChAT-expressing grafts showed significantly improved performance in water maze acquisition, retention, and spatial probe trials compared to those treated with DOX to silence ChAT.
    • Cognitive enhancement was specific to spatial tasks, with no significant changes observed in inhibitory avoidance or open-field activity.
    • Molecular and biochemical data confirmed that DOX effectively regulated ChAT transgene transcription and subsequent acetylcholine levels in the grafted cells.

    Conclusions:

    • Regulatable gene therapy, specifically the controlled expression of choline acetyltransferase, demonstrates significant therapeutic value for cognitive deficits associated with cholinergic dysfunction.
    • The DOX-inducible system provides a powerful tool to precisely control neurotransmitter levels, enabling detailed investigation into the role of specific compounds in discrete behavioral tasks.
    • This approach holds promise for treating single-gene disorders and offers a novel mechanism for spatiotemporal drug delivery in neuroscience research.